📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
CONCORD BIOTECH LIMITEDCONCORDBIOPharmaceuticals
Open
1116.5
High
1137.9
Low
1110.1
Close
1123.3
Volume
43441
Exchange
nse
Time
21-May-2026

Outlook

Score:  

5.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Concord Biotech is  
Short Body
Estimated Stoploss of Concord Biotech is ₹  
1110.1
Concord Biotech has a  
Bullishℹ
 pattern. 
Formation of  
Short Body
 candle pattern indicates the trend direction of Concord Biotech is  
Unpredictableℹ
. 

Trend

Concord Biotech is in  
Sideways trendℹ
. 
Price of Concord Biotech is  
Upℹ
 by  

1.16

%. 
Target
Buy @ 

982.22

Sell @ 

1250.44

Current @ 

1123.3

Volume

The trade volumes of Concord Biotech have become  
Deficientℹ
Though the volume trend for Concord Biotech appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Concord Biotech is  

Down

 by  

91.18

% 

Valuation

The current market price of Concord Biotech is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 2034cr and total assets worth ₹ 2034cr, the balance sheet of Concord Biotech is:  
Balancedℹ
. 
Cashflow
Concord Biotech has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 14cr

. It is  
Downℹ
 by  

227.27

%. 

(*Mar 2025)

48.7% i.e. ₹ 244cr earned in operatingℹ
31.74% i.e. ₹ 159cr spent in investingℹ
19.56% i.e. ₹ 98cr spent in financingℹ
0% in otherℹ
Concord Biotech has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 11cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

51.16% i.e. ₹ 265cr earned in operatingℹ
29.73% i.e. ₹ 154cr spent in investingℹ
19.11% i.e. ₹ 99cr spent in financingℹ
0% in otherℹ
Income
The income of Concord Biotech is  

₹ 260cr

 and  

Profit

 is :  

₹ 60cr

(*Sep 2025)

Concord Biotech Profit is up by:  

90.54

% and Income is Up by:  

70.16

% 

(*Sep 2025)

The income of Concord Biotech is  

₹ 217cr

 and  

Profit

 is :  

₹ 42cr

(*Jun 2025)

Concord Biotech Profit is down by:  

24.49

% and Income is Down by:  

19.38

% 

(*Jun 2025)

The income of Concord Biotech is  

₹ 439cr

 and  

Profit

 is :  

₹ 141cr

(*Mar 2025)

Concord Biotech Profit is up by:  

68.97

% and Income is Up by:  

41.59

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.